Amphotericin B Tamed by Salicylic Acid

Yuming Yu, Peng Chen, Mingxing Gao, Wei Lan, Shijun Sun, Ziwei Ma, Rome Sultani, Yincang Cui, Muhammad Umar, Sher Wali Khan, Xiaodong Cai, Zhenjiang Liang, Hui TanACS 2022 · DOI

Abstract

Although Amphotericin B (AmB) is considered as the "gold standard" treatment for deep fungal infections, owing to its excellent antifungal effect, it often causes severe hemolytic toxicity and nephrotoxicity, which limits its clinical use. We designed and synthesized AmB derivatives by attaching salicylic acid (SA) to the carboxyl group and confirmed their structures using <sup>1</sup>H NMR, <sup>13</sup>C NMR, HR-MS, and IR. We evaluated its biological activity <i>in vitro</i> and measured its ultraviolet-visible (UV-vis) absorption spectrum. The AmB-SA conjugates exhibited good antifungal effects against <i>Candida albicans</i>, <i>Candida glabrata</i>, and <i>Cryptococcus neoformans</i> compared with AmB, and the renal cytotoxicity toward HEK 293T cells <i>in vitro</i> was significantly reduced, with almost no nephrotoxicity in the therapeutic window of the drug. At the same time, the hemolytic toxicity was significantly reduced. Therefore, modification of AmB by introducing SA is an effective strategy to maintain the broad antifungal activity of AmB and reduce its cytotoxicity. These AmB derivatives could be applied in clinical therapy in the future.
BibTeX
@inproceedings{yu2022amphotericin,
  author = {Yuming Yu and Peng Chen and Mingxing Gao and Wei Lan and Shijun Sun and Ziwei Ma and Rome Sultani and Yincang Cui and Muhammad Umar and Sher Wali Khan and Xiaodong Cai and Zhenjiang Liang and Hui Tan},
  title = {{Amphotericin B Tamed by Salicylic Acid}},
  booktitle = {ACS},
  year = {2022},
  doi = {10.1021/acsomega.1c07201},
}

Loading related content...

Figure